Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Raynor MA"'
Autor:
Jafri Hasan S, Connolly John, Kiener Peter A, Raynor Martin B, Chávez-Bueno Susana, Mejías Asunción, Ramilo Octavio
Publikováno v:
Virology Journal, Vol 4, Iss 1, p 109 (2007)
Abstract Motavizumab (MEDI-524) is a monoclonal antibody with enhanced neutralizing activity against RSV. In mice, motavizumab suppressed RSV replication which resulted in significant reduction of clinical parameters of disease severity. We evaluated
Externí odkaz:
https://doaj.org/article/1689097732b7412e8818ebb735301fc9
Autor:
Hennis R; Internal Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, USA., Raynor MA; Internal Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, USA., Hock RA; Internal Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, USA., Yousaf M; Internal Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, USA., Allen JC; Internal Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, USA., Heh E; Internal Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, USA., Bies JJ; Internal Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, USA., Meza A; Division of Infectious Diseases, Texas Tech University Health Sciences Center El Paso, El Paso, USA.
Publikováno v:
Cureus [Cureus] 2024 Oct 23; Vol. 16 (10), pp. e72191. Date of Electronic Publication: 2024 Oct 23 (Print Publication: 2024).